Post

New research · Ophthalmology
European journal of ophthalmology · 1w
Cohort studyEuropean journal of ophthalmology · 2026

Real-world evaluation of anti-VEGF therapy in diabetic macular edema: The role of macular ischemia and OCT biomarkers BOSPHORUS DME study group report no: 14.

Bengi Demirayak, Abdullah Özkaya, İsmail Umut Onur … Veysel Levent Karabaş
Read paper
OphthalmologyCohort study

Diabetic macular edema eyes with macular ischemia had worse baseline vision

Real-world evaluation of anti-VEGF therapy in diabetic macular edema: The role of macular ischemia and OCT biomarkers BOSPHORUS DME study group report no: 14.

Bengi Demirayak … Veysel Levent Karabaş
European journal of ophthalmology · 2026
Purpose

To compare the anatomical and functional outcomes of DME treatment with anti-VEGF between patients with and without macular ischemia and investigate the association between OCT biomarkers and macular ischemia.

Methods

Retrospective, multicenter, real-world analysis.

n = 1004 eyes
Results

eyesight test score at the start was worse (higher score means worse vision)

0.81logMAR
Ischemic
0.55logMAR
Non-ischemic
More results

Based on FFA before treatment, patients were divided into two groups: those with macular ischemia and those without macular ischemia.

Macular ischemia was detected in 238 eyes (23.7%).

More results

After adjustment for baseline covariates, ischemic eyes demonstrated longitudinal BCVA improvement at months 6 and 12 despite persistently lower overall vision levels.

CMT significantly decreased over time in both groups without significant differences in anatomical response.

“
Conclusion · 1 of 2

In real-world settings, eyes with macular ischemia showed meaningful functional and anatomical improvement after anti-VEGF therapy in DME, despite worse visual acuity throughout follow-up.

Conclusion · 2 of 2

Macular ischemia was associated with poorer final visual outcomes but did not preclude treatment response.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment